Literature DB >> 15004781

Measurement of brain glutamate using TE-averaged PRESS at 3T.

Ralph Hurd1, Napapon Sailasuta, Radhika Srinivasan, Daniel B Vigneron, Daniel Pelletier, Sarah J Nelson.   

Abstract

A method is introduced that provides improved in vivo spectroscopic measurements of glutamate (Glu), glutamine (Gln), choline (Cho), creatine (Cre), N-acetyl compounds (NAtot, NAA + NAAG), and the inositols (mI and sI). It was found that at 3T, TE averaging, the f1 = 0 slice of a 2D J-resolved spectrum, yielded unobstructed signals for Glu, Glu + Gln (Glx), mI, NA(tot), Cre, and Cho. The C4 protons of Glu at 2.35 ppm, and the C2 protons of Glx at 3.75 ppm were well resolved and yielded reliable measures of Glu/Gln stasis. Apparent T1/T2 values were obtained from the raw data, and metabolite tissue levels were determined relative to a readily available standard. A repeatibility error of <5%, and a coefficient of variation (CV) of <10% were observed for brain Glu levels in a study of six normal volunteers. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004781     DOI: 10.1002/mrm.20007

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  94 in total

1.  Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.

Authors:  John C Umhau; Reza Momenan; Melanie L Schwandt; Erick Singley; Mariel Lifshitz; Linda Doty; Lauren J Adams; Valentina Vengeliene; Rainer Spanagel; Yan Zhang; Jun Shen; David T George; Daniel Hommer; Markus Heilig
Journal:  Arch Gen Psychiatry       Date:  2010-10

2.  Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T.

Authors:  Andrew P Prescot; Todd Richards; Stephen R Dager; Changho Choi; Perry F Renshaw
Journal:  NMR Biomed       Date:  2012-03-12       Impact factor: 4.044

3.  Signal enhancement of glutamine and glutathione by single-step spectral editing.

Authors:  Li An; Maria Ferraris Araneta; Milalynn Victorino; Jun Shen
Journal:  J Magn Reson       Date:  2020-06-01       Impact factor: 2.229

4.  Two-dimensional linear-combination model fitting of magnetic resonance spectra to define the macromolecule baseline using FiTAID, a Fitting Tool for Arrays of Interrelated Datasets.

Authors:  Daniel G Q Chong; Roland Kreis; Christine S Bolliger; Chris Boesch; Johannes Slotboom
Journal:  MAGMA       Date:  2011-03-20       Impact factor: 2.310

5.  Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder.

Authors:  Thomas Ernst; Caroline S Jiang; Helenna Nakama; Steven Buchthal; Linda Chang
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

6.  GAVA: spectral simulation for in vivo MRS applications.

Authors:  Brian J Soher; Karl Young; Aaron Bernstein; Zakaria Aygula; Andrew A Maudsley
Journal:  J Magn Reson       Date:  2007-01-12       Impact factor: 2.229

Review 7.  Proton MR spectroscopy of the brain at 3 T: an update.

Authors:  Alfonso Di Costanzo; Francesca Trojsi; Michela Tosetti; Timo Schirmer; Silke M Lechner; Teresa Popolizio; Tommaso Scarabino
Journal:  Eur Radiol       Date:  2007-01-18       Impact factor: 5.315

8.  Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T.

Authors:  Jiani Hu; Shaolin Yang; Yang Xuan; Quan Jiang; Yihong Yang; E Mark Haacke
Journal:  J Magn Reson       Date:  2006-12-22       Impact factor: 2.229

9.  Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.

Authors:  Yan Li; Radhika Srinivasan; Helene Ratiney; Ying Lu; Susan M Chang; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

10.  Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy.

Authors:  Shaolin Yang; Betty Jo Salmeron; Thomas J Ross; Zheng-Xiong Xi; Elliot A Stein; Yihong Yang
Journal:  Psychiatry Res       Date:  2009-11-10       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.